» Articles » PMID: 28544405

Trends of Mortality from Alzheimer's Disease in the European Union, 1994-2013

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2017 May 26
PMID 28544405
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: In many countries, Alzheimer's disease (AD) has gradually become a common disease in elderly populations. The aim of this study was to analyse trends of mortality caused by AD in the 28 member countries in the European Union (EU) over the last two decades.

Methods: We extracted data for AD deaths for the period 1994-2013 in the EU from the Eurostat and World Health Organization database. Age-standardized mortality rates per 100 000 were computed. Joinpoint regression was used to analyse the trends and compute the annual percent change in the EU as a whole and by country. Analyses by gender and by European regions were conducted.

Results: Mortality from AD has risen in the EU throughout the study period. Most of the countries showed upward trends, with the sharpest increases in Slovakia, Lithuania and Romania. We recorded statistically significant increases of 4.7% and 6.0% in mortality rates in men and women, respectively, in the whole EU. Several countries showed changing trends during the study period. According to the regional analysis, northern and eastern countries showed the steepest increases, whereas in the latter years mortality has declined in western countries.

Conclusions: Our findings provide evidence that AD mortality has increased in the EU, especially in eastern and northern European countries and in the female population. Our results could be a reference for the development of primary prevention policies.

Citing Articles

Mortality of alzheimer's disease in Italy from 1980 to 2015.

Bezzini D, Smeralda C, Pasqualetti P, Cappa S, Kundisova L, Rossi S Neurol Sci. 2024; 45(12):5731-5737.

PMID: 39404919 PMC: 11554694. DOI: 10.1007/s10072-024-07791-3.


Current Diagnostic Pathways for Alzheimer's Disease: A Cross-Sectional Real-World Study Across Six Countries.

Roth S, Burnie N, Suridjan I, Yan J, Carboni M J Alzheimers Dis Rep. 2023; 7(1):659-674.

PMID: 37483324 PMC: 10357118. DOI: 10.3233/ADR230007.


Mapping trends and hotspots of mitochondrial dysfunction in Alzheimer's disease from 2013 to 2022: a bibliometric analysis of global research.

Guo W, Hassan L, Chu Y, Yang X, Wang S, Zhu H Front Neurosci. 2023; 17:1199625.

PMID: 37434768 PMC: 10330782. DOI: 10.3389/fnins.2023.1199625.


Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology.

Hassan N, Alshamari A, Hassan A, Elharrif M, Alhajri A, Sattam M Molecules. 2022; 27(15).

PMID: 35956796 PMC: 9369981. DOI: 10.3390/molecules27154839.


Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.

Wong H, Zhong H, Zhong M, Zhou X, Chan P, Kwok T J Alzheimers Dis. 2022; 87(3):1205-1213.

PMID: 35466936 PMC: 9198724. DOI: 10.3233/JAD-215312.